SK144698A3 - Immediate release ph-independent solid dosage form of cisapride - Google Patents

Immediate release ph-independent solid dosage form of cisapride Download PDF

Info

Publication number
SK144698A3
SK144698A3 SK1446-98A SK144698A SK144698A3 SK 144698 A3 SK144698 A3 SK 144698A3 SK 144698 A SK144698 A SK 144698A SK 144698 A3 SK144698 A3 SK 144698A3
Authority
SK
Slovakia
Prior art keywords
tablet
dosage form
cisapride
solid dosage
tablets
Prior art date
Application number
SK1446-98A
Other languages
English (en)
Slovak (sk)
Inventor
Paul M V Gilis
Guido F Smans
Guido J M Gijs
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SK144698A3 publication Critical patent/SK144698A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK1446-98A 1996-04-23 1997-03-20 Immediate release ph-independent solid dosage form of cisapride SK144698A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201078 1996-04-23
PCT/EP1997/001462 WO1997039744A1 (en) 1996-04-23 1997-03-20 Immediate release ph-independent solid dosage form of cisapride

Publications (1)

Publication Number Publication Date
SK144698A3 true SK144698A3 (en) 1999-05-07

Family

ID=8223900

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1446-98A SK144698A3 (en) 1996-04-23 1997-03-20 Immediate release ph-independent solid dosage form of cisapride

Country Status (23)

Country Link
US (1) US6030988A (de)
JP (1) JPH10510559A (de)
KR (1) KR100204115B1 (de)
CN (1) CN1216467A (de)
AR (1) AR006790A1 (de)
AT (1) ATE220543T1 (de)
AU (1) AU720582B2 (de)
BG (1) BG102812A (de)
BR (1) BR9708585A (de)
CA (1) CA2201264C (de)
CZ (1) CZ332598A3 (de)
DE (1) DE69713948D1 (de)
EA (1) EA000804B1 (de)
EE (1) EE03552B1 (de)
ID (1) ID16666A (de)
IL (1) IL125979A0 (de)
NO (1) NO984016L (de)
NZ (1) NZ331705A (de)
PL (1) PL328917A1 (de)
SK (1) SK144698A3 (de)
TR (1) TR199802139T2 (de)
WO (1) WO1997039744A1 (de)
ZA (1) ZA973449B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20030138485A1 (en) * 1998-01-14 2003-07-24 Daiichi Pharmaceutical Co., Ltd. Disintegrant
CA2298823C (en) * 1998-04-20 2011-06-07 Eisai Co., Ltd. Stabilized composition comprising a benzimidazole type compound
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
US6353005B1 (en) * 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
MXPA02003762A (es) 1999-10-20 2002-09-30 Eisai Co Ltd Metodos para estabilizar compuestos basados en benzimidazol.
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US7714006B1 (en) 2001-12-03 2010-05-11 King Pharmaceuticals Research & Development, Inc. Methods of modifying the bioavailability of metaxalone
US6407128B1 (en) 2001-12-03 2002-06-18 Elan Pharmaceuticals, Inc. Method for increasing the bioavailability of metaxalone
DE10164510A1 (de) 2001-12-20 2003-07-10 Schering Ag Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes
EP1321142A1 (de) * 2001-12-21 2003-06-25 Novartis AG Feste orale Zubereitung mit Tegaserod
HRP20020124A2 (en) * 2002-02-11 2003-10-31 Pliva D D Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
GB2390541A (en) * 2002-07-12 2004-01-14 Reckitt Benckiser Healthcare Medicinal composition comprising fibre or saccharide bulking agents
WO2004019937A1 (en) * 2002-09-02 2004-03-11 Sun Pharmaceutical Industries Limited Pharmaceutical composition of metaxalone with enhanced oral bioavailability
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005007117A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8138204B2 (en) * 2004-01-07 2012-03-20 Aryx Therapeutics, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
US8524736B2 (en) 2004-01-07 2013-09-03 Armetheon, Inc. Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
EP1718303A4 (de) * 2004-02-10 2010-09-01 Santarus Inc Kombination eines protonenpumpenhemmers, puffermittels und einem nichtsteroidalen entzündungshemmenden mittel
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
US8663681B2 (en) 2005-05-26 2014-03-04 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
CN1935264B (zh) * 2005-09-23 2010-05-05 北京德众万全医药科技有限公司 一种用于缓控释片的含有hpmc的新型复合辅料
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
TW200843802A (en) * 2007-02-09 2008-11-16 Drugtech Corp Compositions for improving gastrointestinal nutrient and drug absorption
CN104352465B (zh) * 2014-11-17 2017-04-12 成都新恒创药业有限公司 一种不含二氧化硅的琥珀酸普芦卡必利药物组合物及其制备方法
TWI808217B (zh) 2018-07-12 2023-07-11 大陸商四川海思科製藥有限公司 稠合三環γ-胺基酸衍生物之組合物及其製備方法
CN109394711A (zh) * 2018-11-06 2019-03-01 威海贯标信息科技有限公司 一种酒石酸西尼必利片组合物
WO2023242796A1 (en) * 2022-06-15 2023-12-21 Varoli Giovan Battista Box for the supply of food products for dysphagic users

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962115A (en) * 1981-10-01 1990-10-09 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
CA2139638A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
EP0651639A4 (de) * 1992-07-07 1996-06-26 Sepracor Inc Verfahren zur verwendung von (+)-cisaprid zur behandlung der reflux-ösophagitis und anderer erkrankungen.
EP0707492A1 (de) * 1993-07-06 1996-04-24 Merck & Co. Inc. Kombinationen aus h 2? antagonisten und gastrointestinalen motilitässubstanzen
DK0670160T3 (da) * 1994-03-01 2000-02-14 Gerhard Gergely Granulært præparat eller tablet omfattende et brusemiddel og et aktivt farmaceutisk stof samt fremgangsmåde til dets fremst
CH686865A5 (de) * 1994-06-15 1996-07-31 Gergely Gerhard Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
EE9800269A (et) 1999-02-15
AU2290497A (en) 1997-11-12
AR006790A1 (es) 1999-09-29
WO1997039744A1 (en) 1997-10-30
ZA973449B (en) 1998-10-22
EA000804B1 (ru) 2000-04-24
AU720582B2 (en) 2000-06-08
CA2201264A1 (en) 1997-10-23
JPH10510559A (ja) 1998-10-13
KR970069038A (ko) 1997-11-07
ID16666A (id) 1997-10-30
US6030988A (en) 2000-02-29
BR9708585A (pt) 1999-08-03
BG102812A (en) 1999-05-31
IL125979A0 (en) 1999-04-11
CZ332598A3 (cs) 1999-01-13
PL328917A1 (en) 1999-03-01
NO984016D0 (no) 1998-09-01
NZ331705A (en) 1999-11-29
EE03552B1 (et) 2001-12-17
KR100204115B1 (ko) 1999-06-15
DE69713948D1 (de) 2002-08-22
ATE220543T1 (de) 2002-08-15
NO984016L (no) 1998-12-23
EA199800861A1 (ru) 1999-02-25
CN1216467A (zh) 1999-05-12
TR199802139T2 (xx) 1999-03-22
CA2201264C (en) 1999-08-10

Similar Documents

Publication Publication Date Title
SK144698A3 (en) Immediate release ph-independent solid dosage form of cisapride
US20220133778A1 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1100469B1 (de) Leicht zerfallende feste zubereitung
CN108969490A (zh) 快速分散颗粒、口腔崩解片以及方法
PL200957B1 (pl) Kompozycja farmaceutyczna celecoxib'u i zastosowanie kompozycji farmaceutycznej
WO2006127044A2 (en) Pharmaceutical formulations useful for inhibiting acid secretion
JP2025126303A (ja) 錠剤、その製造方法、および医薬品
JP2004533461A (ja) パラセタモールを含む嚥下錠剤
IL139407A (en) Oral preparations containing -8 chloro-6, 11 - dihydro-11 - (-4-piperidaldehyde) - H5-benzo [5, 6] cyclohepta [1, -2 [b-pyridine
EP0803251B1 (de) Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
EP1931314A2 (de) Ramipril-formulierung
EP0988032A1 (de) Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend (+)- oder (-)-cisaprid
US8653135B1 (en) Alternating sympathomimetic therapy for the treatment of respiratory aliments
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤（乾式）
MXPA98008710A (en) Dosage form solid independent of the ph, of immediate release
SK19192000A3 (sk) Použitie paroxetínu alebo jeho farmaceuticky prijateľnej soli alebo solvátu na podporu odvykania od fajčenia alebo na zníženie alebo prevenciu relapsu fajčenia
JP6832195B2 (ja) 経口液剤及び経口固形剤
KR20050002856A (ko) 염산 필지카이니드 함유 정제(습식)
AU2011265561B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2005331781B2 (en) Pharmaceutical formulations useful for inhibiting acid secretion
US20020192293A1 (en) Method for manufacture of extended release dosage form
HK40031570A (en) Novel fine particle coating (drug-containing hollow particle and method for manufacturing same)
HK1018399A (en) Immediate release ph-independent solid dosage form of cisapride
MXPA00007471A (es) Composiciones de celecoxib
US20170202804A1 (en) Water dispersible mini-tablets comprising enalapril for treatment of hypertension in a pediatric population and method of preparation thereof